Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 526 across all filing types
Latest filing 2025-12-29 Regulatory Filings
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification about the closure of the trading window in compliance with insider trading regulations, specifically mentioning the period around the announcement of unaudited financial results for a quarter and nine months ending December 31, 2025. It does not contain any financial data or results itself, nor does it present or discuss the financial results. It is an announcement related to trading restrictions prior to the release of financial results. The document is short (1749 characters) and serves as a regulatory compliance notice rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2025-12-29 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the incorporation of a wholly owned subsidiary company. It references compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which pertains to disclosure of material events or information. The content is an announcement of a corporate event (subsidiary incorporation) rather than a financial report, management discussion, or other detailed filings. The document length is short (2244 characters) and it serves as an intimation or announcement to the exchange and public. This fits the category of a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit into more specific categories like Annual Report, Earnings Release, or Management Information. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-12-18 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the outcome of a Board Meeting held on December 18, 2025. It discloses the approval for incorporation of a wholly owned subsidiary in Singapore, including details required under SEBI Listing Regulations. The content focuses on a corporate action (incorporation of a subsidiary) and compliance with regulatory disclosure requirements under SEBI Regulation 30. There are no financial statements or detailed financial performance data presented, nor is this a report or earnings release. It is a regulatory announcement about a corporate event approved by the Board. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and compliance disclosure that does not fit into more specific categories like MANG (management changes) or CAP (capital/financing update) since it is about incorporation of a subsidiary and related disclosures under SEBI regulations.
2025-12-18 English
Credit Rating
Interest Rate Update/Notice Classification · 95% confidence The document is a formal communication regarding the reaffirmation of credit ratings by ICRA Limited for various financial instruments of Rossari Biotech Limited. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations for listed companies. The content includes detailed credit rating information, rating actions, and terms related to the company's debt instruments. There are no financial statements, management discussion, or earnings data presented. The document is an update on credit rating status, which is a type of interest rate or credit rating update affecting the company's debt instruments. It is not an annual report, earnings release, or audit report. Given the nature of the content, the most appropriate classification is Interest Rate Update/Notice (IRAT).
2025-12-03 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges (BSE and NSE) regarding an update on the approval for purchase of rights in leasehold land by a subsidiary. It references compliance with SEBI Listing Regulations and previous intimation letters. The content is an announcement of a corporate event (purchase of leasehold land rights) and is regulatory in nature. The document is short (2114 characters) and does not contain financial statements, detailed financial data, or management discussion. It is not an annual report, interim report, earnings release, or any detailed financial or governance report. It is a regulatory disclosure under Listing Regulations, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-11-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation to stock exchanges about a scheduled investors and analysts meeting/conference. It references a prior earnings presentation submitted on October 16, 2025, but does not contain any financial data or detailed report itself. The document is short (2021 characters) and serves as a notification of an event rather than a report or transcript. It explicitly states that no unpublished price sensitive information will be shared. This fits the category of an Investor Presentation announcement or meeting notice, but since it is primarily an announcement of the meeting and references a previously submitted earnings presentation, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain the actual presentation or transcript. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-11-06 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.